Plant-Based Biologics Market By Product Type (Leaf-based, Seed-Based, Fruit-based, Others), By Source (Carrot, Tobacco, Rice, Duckweed, Others), By Target Disease (Gaucher Disease, Fabry Disease, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global Plant-based biologics market is envisioned to garner $182.9 million by 2031, growing from $116.1 million in 2021 at a CAGR of 4.8% from 2022 to 2031.
The current production platforms, which are mostly based on mammalian cell culture, cannot meet the expanding global demand for human biologics due to exorbitant costs and restricted scalability. However, recent advances in plant expression vector generation, downstream processing, and glycoengineering have established plants as a preferable alternative for biologic production. Plant-based methods not only provide typical benefits such as appropriate eukaryotic protein modification, cheap cost, high scalability, and higher safety, but also enable for the rapid manufacture of biologics to control possible pandemics or with specialized glycoforms for improved efficacy or safety. The use of plant-based biologics has several advantages, including the ability to produce complex molecules at a lower cost than traditional systems, scalability to meet global demand, and improved safety due to the lack of potential human pathogens.
Environmental conditions, plant genetics, and post-harvest processing all have an impact on the quality of plant-based biologics. These factors can have an effect on the uniformity and purity of the end product, which is critical for the safety of biologics and efficacy. Ensuring consistent and high-quality production of plant-based biologics necessitates specialized knowledge and expertise, which may be absent in some instances. These factors are anticipated to hamper the growth of the plant-based biologics market growth.
The plant-based biologics market has expanded fast in recent years, driven by rise in biologics demand and the desire for more cost-effective and sustainable manufacturing methods. Duckweed plants are little water plants that grow quickly and are easy to cultivate. They are being researched as a potential platform for the manufacture of a wide range of biologics, including antibodies, enzymes, and vaccines. Duckweed plants have an advantage in biologics manufacturing because they can perform post-translational changes similar to mammalian cells, leading to proteins that closely resemble human proteins. Moreover, duckweed plants can generate biologics at a significantly lower cost than typical manufacturing platforms, making them a more cost-effective and scalable solution.
The pandemic of COVID-19 has had a substantial influence on many industries, including the plant-based biologics industry. The epidemic caused interruptions in the biologics supply chain, manufacturing, and distribution, which hampered growth of the industry. The pandemic has also caused delays in clinical trials and the approval process for novel biologics. Many companies were forced to suspend their research and development activities, resulting in a slowdown in the development of new products. Furthermore, the COVID-19 pandemic has caused significant disruptions to the global workforce, resulting in a reduced availability of skilled workers. The pandemic has forced many businesses to close temporarily or permanently, leading to job losses and decreased economic activity. In addition, many workers have been hesitant to return to work due to concerns about their health and safety. However, the pandemic has underlined the significance of creating more sustainable and cost-effective biologic production technologies. This has led to an increased interest in plant-based biologics, which have the potential to be produced at a lower cost and with faster turnaround times than traditional production methods.
The key players profiled in this report include Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., and Eleva GmbH
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the plant-based biologics market analysis from 2021 to 2031 to identify the prevailing plant-based biologics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the plant-based biologics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global plant-based biologics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Leaf-based
Seed-Based
Fruit-based
Others
By Source
Carrot
Tobacco
Rice
Duckweed
Others
By Target Disease
Gaucher Disease
Fabry Disease
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
UAE
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Leaf Expression Systems
Zea Biosciences
Planet Biotechnology Inc.
InVitria
plantform corporation
IBIO, Inc.
Mapp Biopharmaceutical, Inc.
Ventria Bioscience Inc.
Medicago Inc.
Eleva GmbH
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- 3.5. COVID-19 Impact Analysis on the market
- 3.6. Average Selling Price
- 3.7. Brand Share Analysis
- 3.8. Key Regulation Analysis
- 3.9. Market Share Analysis
- 3.10. Patent Landscape
- 3.11. Regulatory Guidelines
- 3.12. Value Chain Analysis
- CHAPTER 4: PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Leaf-based
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Seed-Based
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Fruit-based
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.5. Others
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
- CHAPTER 5: PLANT-BASED BIOLOGICS MARKET, BY SOURCE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Carrot
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Tobacco
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Rice
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Duckweed
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- 5.6. Others
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
- CHAPTER 6: PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Gaucher Disease
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Fabry Disease
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: PLANT-BASED BIOLOGICS MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Source
- 7.2.4. Market size and forecast, by Target Disease
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Product Type
- 7.2.5.1.3. Market size and forecast, by Source
- 7.2.5.1.4. Market size and forecast, by Target Disease
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Product Type
- 7.2.5.2.3. Market size and forecast, by Source
- 7.2.5.2.4. Market size and forecast, by Target Disease
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Product Type
- 7.2.5.3.3. Market size and forecast, by Source
- 7.2.5.3.4. Market size and forecast, by Target Disease
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Source
- 7.3.4. Market size and forecast, by Target Disease
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Product Type
- 7.3.5.1.3. Market size and forecast, by Source
- 7.3.5.1.4. Market size and forecast, by Target Disease
- 7.3.5.2. UK
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Product Type
- 7.3.5.2.3. Market size and forecast, by Source
- 7.3.5.2.4. Market size and forecast, by Target Disease
- 7.3.5.3. France
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Product Type
- 7.3.5.3.3. Market size and forecast, by Source
- 7.3.5.3.4. Market size and forecast, by Target Disease
- 7.3.5.4. Spain
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Product Type
- 7.3.5.4.3. Market size and forecast, by Source
- 7.3.5.4.4. Market size and forecast, by Target Disease
- 7.3.5.5. Italy
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Product Type
- 7.3.5.5.3. Market size and forecast, by Source
- 7.3.5.5.4. Market size and forecast, by Target Disease
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Product Type
- 7.3.5.6.3. Market size and forecast, by Source
- 7.3.5.6.4. Market size and forecast, by Target Disease
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Source
- 7.4.4. Market size and forecast, by Target Disease
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. China
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Product Type
- 7.4.5.1.3. Market size and forecast, by Source
- 7.4.5.1.4. Market size and forecast, by Target Disease
- 7.4.5.2. Japan
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Product Type
- 7.4.5.2.3. Market size and forecast, by Source
- 7.4.5.2.4. Market size and forecast, by Target Disease
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Product Type
- 7.4.5.3.3. Market size and forecast, by Source
- 7.4.5.3.4. Market size and forecast, by Target Disease
- 7.4.5.4. South Korea
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Product Type
- 7.4.5.4.3. Market size and forecast, by Source
- 7.4.5.4.4. Market size and forecast, by Target Disease
- 7.4.5.5. Australia
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Product Type
- 7.4.5.5.3. Market size and forecast, by Source
- 7.4.5.5.4. Market size and forecast, by Target Disease
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Product Type
- 7.4.5.6.3. Market size and forecast, by Source
- 7.4.5.6.4. Market size and forecast, by Target Disease
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Source
- 7.5.4. Market size and forecast, by Target Disease
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Product Type
- 7.5.5.1.3. Market size and forecast, by Source
- 7.5.5.1.4. Market size and forecast, by Target Disease
- 7.5.5.2. UAE
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Product Type
- 7.5.5.2.3. Market size and forecast, by Source
- 7.5.5.2.4. Market size and forecast, by Target Disease
- 7.5.5.3. Saudi Arabia
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Product Type
- 7.5.5.3.3. Market size and forecast, by Source
- 7.5.5.3.4. Market size and forecast, by Target Disease
- 7.5.5.4. South Africa
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Product Type
- 7.5.5.4.3. Market size and forecast, by Source
- 7.5.5.4.4. Market size and forecast, by Target Disease
- 7.5.5.5. Rest of LAMEA
- 7.5.5.5.1. Key market trends, growth factors and opportunities
- 7.5.5.5.2. Market size and forecast, by Product Type
- 7.5.5.5.3. Market size and forecast, by Source
- 7.5.5.5.4. Market size and forecast, by Target Disease
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1. Leaf Expression Systems
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.2. Zea Biosciences
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.3. Planet Biotechnology Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.4. InVitria
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.5. plantform corporation
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.6. IBIO, Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.7. Mapp Biopharmaceutical, Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.8. Ventria Bioscience Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.9. Medicago Inc.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.10. Eleva GmbH
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- LIST OF TABLES
- TABLE 01. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 02. PLANT-BASED BIOLOGICS MARKET FOR LEAF-BASED, BY REGION, 2021-2031 ($MILLION)
- TABLE 03. PLANT-BASED BIOLOGICS MARKET FOR SEED-BASED, BY REGION, 2021-2031 ($MILLION)
- TABLE 04. PLANT-BASED BIOLOGICS MARKET FOR FRUIT-BASED, BY REGION, 2021-2031 ($MILLION)
- TABLE 05. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 06. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 07. PLANT-BASED BIOLOGICS MARKET FOR CARROT, BY REGION, 2021-2031 ($MILLION)
- TABLE 08. PLANT-BASED BIOLOGICS MARKET FOR TOBACCO, BY REGION, 2021-2031 ($MILLION)
- TABLE 09. PLANT-BASED BIOLOGICS MARKET FOR RICE, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. PLANT-BASED BIOLOGICS MARKET FOR DUCKWEED, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 13. PLANT-BASED BIOLOGICS MARKET FOR GAUCHER DISEASE, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. PLANT-BASED BIOLOGICS MARKET FOR FABRY DISEASE, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. PLANT-BASED BIOLOGICS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 18. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 19. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 20. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. U.S. PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 22. U.S. PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 23. U.S. PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 24. CANADA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 25. CANADA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 26. CANADA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 27. MEXICO PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 28. MEXICO PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 29. MEXICO PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 30. EUROPE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 31. EUROPE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 32. EUROPE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 33. EUROPE PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 34. GERMANY PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 35. GERMANY PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 36. GERMANY PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 37. UK PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 38. UK PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 39. UK PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 40. FRANCE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 41. FRANCE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 42. FRANCE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 43. SPAIN PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 44. SPAIN PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 45. SPAIN PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 46. ITALY PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 47. ITALY PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 48. ITALY PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 49. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 50. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 51. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 52. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 53. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 54. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 55. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 56. CHINA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 57. CHINA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 58. CHINA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 59. JAPAN PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 60. JAPAN PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 61. JAPAN PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 62. INDIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 63. INDIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 64. INDIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 65. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 66. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 67. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 68. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 69. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 70. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 74. LAMEA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 75. LAMEA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 76. LAMEA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 77. LAMEA PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 78. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 79. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 80. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 81. UAE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 82. UAE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 83. UAE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 84. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 85. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 86. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 87. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 88. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 89. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 90. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 91. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 92. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
- TABLE 93. LEAF EXPRESSION SYSTEMS: KEY EXECUTIVES
- TABLE 94. LEAF EXPRESSION SYSTEMS: COMPANY SNAPSHOT
- TABLE 95. ZEA BIOSCIENCES: KEY EXECUTIVES
- TABLE 96. ZEA BIOSCIENCES: COMPANY SNAPSHOT
- TABLE 97. PLANET BIOTECHNOLOGY INC.: KEY EXECUTIVES
- TABLE 98. PLANET BIOTECHNOLOGY INC.: COMPANY SNAPSHOT
- TABLE 99. INVITRIA: KEY EXECUTIVES
- TABLE 100. INVITRIA: COMPANY SNAPSHOT
- TABLE 101. PLANTFORM CORPORATION: KEY EXECUTIVES
- TABLE 102. PLANTFORM CORPORATION: COMPANY SNAPSHOT
- TABLE 103. IBIO, INC.: KEY EXECUTIVES
- TABLE 104. IBIO, INC.: COMPANY SNAPSHOT
- TABLE 105. MAPP BIOPHARMACEUTICAL, INC.: KEY EXECUTIVES
- TABLE 106. MAPP BIOPHARMACEUTICAL, INC.: COMPANY SNAPSHOT
- TABLE 107. VENTRIA BIOSCIENCE INC.: KEY EXECUTIVES
- TABLE 108. VENTRIA BIOSCIENCE INC.: COMPANY SNAPSHOT
- TABLE 109. MEDICAGO INC.: KEY EXECUTIVES
- TABLE 110. MEDICAGO INC.: COMPANY SNAPSHOT
- TABLE 111. ELEVA GMBH: KEY EXECUTIVES
- TABLE 112. ELEVA GMBH: COMPANY SNAPSHOT
- LIST OF FIGURES
- FIGURE 01. PLANT-BASED BIOLOGICS MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF PLANT-BASED BIOLOGICS MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN PLANT-BASED BIOLOGICS MARKET (2022-2031)
- FIGURE 04. PORTER FIVE-1
- FIGURE 05. PORTER FIVE-2
- FIGURE 06. PORTER FIVE-3
- FIGURE 07. PORTER FIVE-4
- FIGURE 08. PORTER FIVE-5
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPLANT-BASED BIOLOGICS MARKET
- FIGURE 10. IMPACT OF KEY REGULATION: PLANT-BASED BIOLOGICS MARKET
- FIGURE 11. MARKET SHARE ANALYSIS: PLANT-BASED BIOLOGICS MARKET
- FIGURE 12. PATENT ANALYSIS BY COMPANY
- FIGURE 13. PATENT ANALYSIS BY COUNTRY
- FIGURE 14. REGULATORY GUIDELINES: PLANT-BASED BIOLOGICS MARKET
- FIGURE 15. VALUE CHAIN ANALYSIS: PLANT-BASED BIOLOGICS MARKET
- FIGURE 16. PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR LEAF-BASED, BY COUNTRY 2021 AND 2031(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR SEED-BASED, BY COUNTRY 2021 AND 2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR FRUIT-BASED, BY COUNTRY 2021 AND 2031(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 21. PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR CARROT, BY COUNTRY 2021 AND 2031(%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR TOBACCO, BY COUNTRY 2021 AND 2031(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR RICE, BY COUNTRY 2021 AND 2031(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR DUCKWEED, BY COUNTRY 2021 AND 2031(%)
- FIGURE 26. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 27. PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021(%)
- FIGURE 28. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR GAUCHER DISEASE, BY COUNTRY 2021 AND 2031(%)
- FIGURE 29. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR FABRY DISEASE, BY COUNTRY 2021 AND 2031(%)
- FIGURE 30. COMPARATIVE SHARE ANALYSIS OF PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 31. PLANT-BASED BIOLOGICS MARKET BY REGION, 2021
- FIGURE 32. U.S. PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 33. CANADA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 34. MEXICO PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 35. GERMANY PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 36. UK PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 37. FRANCE PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 38. SPAIN PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 39. ITALY PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 40. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 41. CHINA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 42. JAPAN PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 43. INDIA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 44. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 45. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 46. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 47. BRAZIL PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 48. UAE PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 49. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 50. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 51. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, 2021-2031 ($MILLION)
- FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 55. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 56. COMPETITIVE DASHBOARD
- FIGURE 57. COMPETITIVE HEATMAP: PLANT-BASED BIOLOGICS MARKET
- FIGURE 58. TOP PLAYER POSITIONING, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook